Coming off GLP-1 drugs doesn’t have to mean inevitable weight gain. Giulia Crouch asks doctors what you can do to keep it off ...

Novo Nordisk (NYSE: NVO) stock is testing the patience of buy-and-hold investors. Over the last five years, NVO stock is up more than 200%. However, in the last year, it’s down over 61% and more than ...